DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Ferrante F, Ingham S, Kunze M, Michaels LA.
Anti-TFPI antibody BAY-1093884: early termination of phase II dose-escalation study due to thrombosis.
Haemophilia 2020;
26: 77-78
We do not assume any responsibility for the contents of the web pages of other providers.